TFF Pharmaceuticals, Inc. (TFFP)
USD 0.07
(-60.05%)
USD 0.07
(-60.05%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 733.87 Thousand | - | - | - | - | - |
| Cost of Revenue | 502.48 Thousand | 388.22 Thousand | 111.45 Thousand | - | - | - |
| Gross Profit | 231.39 Thousand | -388.22 Thousand | -111.45 Thousand | - | - | - |
| Operating Expenses | 22.62 Million | 31.79 Million | 31.78 Million | 18.69 Million | 11.98 Million | 3.89 Million |
| Selling, General and Administrative Expenses | 10.56 Million | 13.79 Million | 10.57 Million | 8.01 Million | 3.16 Million | 3.04 Million |
| Research and Development Expenses | 11.55 Million | 18.49 Million | 21.3 Million | 10.68 Million | 8.82 Million | 848.8 Thousand |
| Other Expenses | - | -495.8 Thousand | -88.16 Thousand | - | - | - |
| Cost and Expenses | 22.62 Million | 31.79 Million | 31.78 Million | 18.69 Million | 11.98 Million | 3.89 Million |
| Operating Income | -21.89 Million | -31.79 Million | -31.78 Million | -18.69 Million | -11.98 Million | -3.89 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -26.73 | -51.23 Thousand | -126.41 Thousand | -117.32 Thousand | - |
| Earnings before Tax | -21.24 Million | -31.77 Million | -31.03 Million | -18.56 Million | -11.87 Million | -3.84 Million |
| Net Income | -21.24 Million | -31.77 Million | -30.98 Million | -18.44 Million | -11.75 Million | -3.84 Million |
| Earnings Per Share Basic | -11.85 | -26.49 | -31.21 | -22.57 | -42.55 | -5.21 |
| Earnings Per Share Diluted | -11.85 | -26.49 | -31.21 | -22.57 | -42.55 | -5.21 |
| Weighted Average Shares Outstanding | 1.79 Million | 1.19 Million | 992.83 Thousand | 817 Thousand | 276.19 Thousand | 738.03 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 1.79 Million | 1.19 Million | 992.83 Thousand | 817 Thousand | 276.19 Thousand | 738.03 Thousand |
| Gross Margin | 0.32 | - | - | - | - | - |
| EBIT Margin | -28.26 | - | - | - | - | - |
| Profit Margin | -28.95 | - | - | - | - | - |
| EBITDA | -20.74 Million | -31.4 Million | -30.92 Million | -18.69 Million | -11.98 Million | -3.89 Million |
| Earnings Before Tax Margin | -29.83 | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 650.22 Thousand | 203.27 Thousand | 733.87 Thousand | 733.87 Thousand | - | 333.35 Thousand |
| Cost of Revenue | 140.59 Thousand | 140.18 Thousand | 502.48 Thousand | 130.66 Thousand | 125.11 Thousand | 123.52 Thousand |
| Gross Profit | 509.63 Thousand | 63.09 Thousand | 231.39 Thousand | 603.2 Thousand | -125.11 Thousand | 209.82 Thousand |
| Operating Expenses | 4.47 Million | 5.85 Million | 22.12 Million | 5.35 Million | 4.42 Million | 5.01 Million |
| Selling, General and Administrative Expenses | 1.88 Million | 2.29 Million | - | 2.37 Million | 2.26 Million | 2.67 Million |
| Research and Development Expenses | 2.58 Million | 3.55 Million | - | 2.97 Million | 2.38 Million | 2.68 Million |
| Other Expenses | - | - | - | 166.29 Thousand | -77.45 Thousand | -37.41 Thousand |
| Cost and Expenses | 4.61 Million | 5.99 Million | 22.62 Million | 5.48 Million | 4.42 Million | 5.01 Million |
| Operating Income | -4.61 Million | -5.99 Million | -22.62 Million | -5.48 Million | -4.42 Million | -5.01 Million |
| Interest Expense | - | - | - | 158.24 Thousand | - | - |
| Income Tax Expense | -2.00 | -3.00 | - | 4.00 | -88.81 Thousand | -36.12 Thousand |
| Earnings before Tax | -4.47 Million | -5.73 Million | -21.24 Million | -4.76 Million | -4.4 Million | -5.02 Million |
| Net Income | -4.47 Million | -5.73 Million | -21.24 Million | -4.76 Million | -4.4 Million | -5.02 Million |
| Earnings Per Share Basic | -1.22 | -2.40 | - | -2.01 | -2.32 | -3.47 |
| Earnings Per Share Diluted | -1.22 | -2.40 | - | -2.01 | -2.32 | -3.47 |
| Weighted Average Shares Outstanding | 3.66 Million | 2.38 Million | 1.79 Million | 2.36 Million | 1.89 Million | 1.44 Million |
| Weighted Average Shares Outstanding (Diluted) | 3.66 Million | 2.38 Million | 1.79 Million | 2.36 Million | 1.89 Million | 1.44 Million |
| Gross Margin | 0.78 | 0.31 | 0.32 | 0.82 | - | 0.63 |
| EBIT Margin | -6.88 | -28.80 | - | -7.29 | - | -14.69 |
| Profit Margin | -6.89 | -28.21 | -28.95 | -6.49 | - | -15.06 |
| EBITDA | -4.47 Million | -5.85 Million | - | -5.35 Million | -4.29 Million | -4.89 Million |
| Earnings Before Tax Margin | -7.09 | -29.49 | -30.83 | -7.47 | - | -15.06 |
MGU
EPSN
0931
1414
0KUT
ANZ